Analysis of the actual cost and patient burden of belumosudil after medical insurance reimbursement

Belumosudil (belumosudil), as a new type of oral anti-fibrosis and anti-tumor drug, has been officially launched in China and included in the medical insurance catalog. This move has greatly reduced the financial burden on patients, allowing more patients to afford this innovative drug for certain difficult-to-treat diseases. Patients can purchase Besudil through regular hospital pharmacies and enjoy the price discounts brought by the medical insurance policy.

Although after being included in medical insurance, the actual cost of drug purchase by patients has dropped significantly compared with the original price, the price of Besudil is still relatively high. The market price is usually between RMB 10,000 and RMB 20,000. The specific reimbursement ratio and actual patient burden vary depending on regional medical insurance policies. Under normal circumstances, patients need to pay part of the cost out of pocket, and the specific amount needs to be consulted at the local hospital pharmacy to obtain accurate reimbursement and payment information.

Compared with the high price of the domestic original drug, there is a generic version of Besudil in the overseas market, with a price of about 4000 RMB, which has obvious cost advantages. This provides patients with more choices, especially for patients who cannot afford the high cost, making overseas generic drugs a viable alternative. However, when purchasing overseas drugs, you need to pay attention to drug quality assurance and legal channels to avoid risks caused by purchasing informal drugs.

To sum up, after besudil is included in medical insurance, the financial burden of patients has been eased, but the actual cost still needs to be evaluated based on specific medical insurance policies and personal circumstances. Patients should actively communicate with the hospital pharmacy when taking medication to understand the reimbursement details, and at the same time, reasonably weigh domestic and foreign drug options to ensure the safety and economy of medication.

Reference materials:https://www.drugs.com/